| 1. | Centers for Disease Control nearly 24 million Americans have type 2 diabetes mellitus (T2DM); of these 6 million individuals ... GLP-1 glucagon-like peptide-1; T2DM type 2 diabetes mellitus. Treatment of T2DM can be accomplished by targeting ... |
| 2. | therapy: A new paradigm in the treatment of type 2 diabetes.” This activity is provided by the Network for Continuing ... Now the next slide shows the natural history of type 2 diabetes. The majority of people as they develop central ... |
| 3. | 2 diabetes. Low levels are not necessarily an indication of type 1 however because patients with type 2 diabetes may ... Most cases of type 1 diabetes are diagnosed in patients younger than 18 years. But type 1 diabetes is increasingly recognized as a disorder ... |
| 4. | Summarize challenges and barriers to good glycemic control for patients with type 2 diabetes mellitus (t2Dm) 2. ... Centers for Disease Control nearly 24 million Americans have type 2 diabetes mellitus (T2DM); of these 6 million individuals ... |
| 5. | Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin sulfonylurea or thiazolidinedione monotherapy. ... Emerging concepts in the pathophysiology of type 2 diabetes mellitus. Mt Sinai J Med. 2009;76:216–226. ... |
| 6. | 1 While type 2 diabetes comprises 90% to 95% of all diagnosed cases 1 both types put patients ... JAMA. 2001;285:2486-2497. 9. Wilson PWF. Diabetes mellitus and coronary heart disease. ... |
| 7. | 2 diabetes. Type 2 diabetes often occurs with obesity and an associated dysregulation of appetite. ... 3 Abnormalities in insulin secretion resulting from β-cell dysfunction in patients with type 2 diabetes include absence of pulsatility loss of early-phase insulin ... |
| 8. | This state-of-the-art webcast will provide a concise practical evidence-based overview of type 2 diabetes the comorbidities associated with type 2 diabetes ... case-based educational program that provides upto-date evidence-based information on type 2 diabetes and appropriate antihyperglycemic therapy. ... |
| 9. | Summarize challenges and barriers to good glycemic control for patients with type 2 diabetes mellitus (T2DM) Identify patients at risk for T2DM ... reduce microvascular and neuropathic complications of type 1 and type 2 diabetes. Therefore for microvascular disease prevention the A1C goal ... |
| 10. | Glycemic control with diet sulfonylurea metformin or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). ... progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. ... |
;toggleImage('BtImage','images/icons/minus-icon.gif','images/icons/plus-icon.gif');){kind=icon}
Broaden Your Search;toggleImage('NtImage','images/icons/minus-icon.gif','images/icons/plus-icon.gif');){kind=icon}
Narrow Your Search;toggleImage('RtImage','images/icons/minus-icon.gif','images/icons/plus-icon.gif');){kind=icon}
Related Terms